Pseudomonas aeruginosa PA7 is a mesophilic human pathogen that has multiple antibiotic resistances and was isolated from non-respiratory human isolate.
antibiotic resistance mesophilic human pathogen| @ref 20215 |
|
|
| Domain Pseudomonadati |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Pseudomonadales |
| Family Pseudomonadaceae |
| Genus Pseudomonas |
| Species Pseudomonas aeruginosa |
| Full scientific name Pseudomonas aeruginosa (Schroeter 1872) Migula 1900 (Approved Lists 1980) |
| Synonyms (2) |
| @ref: | 6393 |
| multimedia content: | DSM_24068.jpg |
| multimedia.multimedia content: | https://www.dsmz.de/microorganisms/photos/DSM_24068.jpg |
| intellectual property rights: | © Leibniz-Institut DSMZ |
| manual_annotation: | 1 |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 6393 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 6393 | TRYPTICASE SOY BROTH AGAR (DSMZ Medium 535) | Medium recipe at MediaDive | Name: TRYPTICASE SOY BROTH AGAR (DSMZ Medium 535) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Distilled water |
| @ref | Growth | Type | Temperature (°C) | Range | |
|---|---|---|---|---|---|
| 6393 | positive | growth | 28 | mesophilic |
| Test 1 | Test 2 | |
|---|---|---|
| @ref | 6393 | 6393 |
| Medium | Mueller-Hinton Agar | Mueller-Hinton Agar |
| Incubation temperature | 30 | 30 |
| Oxygen condition | aerob | aerob |
| Manual_annotation | 1 | 1 |
| Inhibition zone diameter in mm | Inhibition zone diameter in mm | |
| Penicillin G | 0 | 0 |
| Oxacillin | 0 | 0 |
| Ampicillin | 0 | 0 |
| Ticarcillin | 6 | 6 |
| Mezlocillin | 0 | 0 |
| Cefalotin | 0 | 0 |
| Cefazolin | 0 | 0 |
| Cefotaxime | 0 | 0 |
| Aztreonam | 6 | 6 |
| Imipenem | 30 | 30 |
| Tetracycline | 16 | 16 |
| Chloramphenicol | 0 | 0 |
| Gentamycin | 0 | 0 |
| Amikacin | 18 | 18 |
| Vancomycin | 0 | 0 |
| Erythromycin | 0 | 0 |
| Lincomycin | 0 | 0 |
| Ofloxacin | 0 | 0 |
| Norfloxacin | 0 | 0 |
| Colistin | 16 | 16 |
| Pipemidic acid | 0 | 0 |
| Nitrofurantoin | 0 | 0 |
| Bacitracin | 0 | 0 |
| Polymyxin b | 18 | 18 |
| Kanamycin | 0 | 0 |
| Neomycin | 0 | 0 |
| Doxycycline | 12 | 12 |
| Ceftriaxone | 0 | 0 |
| Clindamycin | 0 | 0 |
| Fosfomycin | 0 | 0 |
| Moxifloxacin | 0 | 0 |
| Linezolid | 0 | 0 |
| Nystatin | 0 | 0 |
| Quinupristin/dalfopristin | 0 | 0 |
| Teicoplanin | 0 | 0 |
| Piperacillin/tazobactam | 0 | 0 |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68369 | 17128 ChEBI | adipate | + | assimilation | from API 20NE |
| 68369 | 29016 ChEBI | arginine | + | hydrolysis | from API 20NE |
| 68369 | 17634 ChEBI | D-glucose | + | assimilation | from API 20NE |
| 68369 | 17634 ChEBI | D-glucose | - | fermentation | from API 20NE |
| 68369 | 16899 ChEBI | D-mannitol | + | assimilation | from API 20NE |
| 68369 | 16024 ChEBI | D-mannose | - | assimilation | from API 20NE |
| 68369 | 27689 ChEBI | decanoate | + | assimilation | from API 20NE |
| 68369 | 4853 ChEBI | esculin | - | hydrolysis | from API 20NE |
| 68369 | 5291 ChEBI | gelatin | + | hydrolysis | from API 20NE |
| 68369 | 24265 ChEBI | gluconate | + | assimilation | from API 20NE |
| 68369 | 30849 ChEBI | L-arabinose | - | assimilation | from API 20NE |
| 68369 | 25115 ChEBI | malate | + | assimilation | from API 20NE |
| 68369 | 17306 ChEBI | maltose | - | assimilation | from API 20NE |
| 68369 | 59640 ChEBI | N-acetylglucosamine | + | assimilation | from API 20NE |
| 68369 | 27897 ChEBI | tryptophan | - | energy source | from API 20NE |
| @ref | Sample type | Geographic location | Country | Country ISO 3 Code | Continent | |
|---|---|---|---|---|---|---|
| 6393 | non-respiratory human isolate | Buenos Aires | Argentina | ARG | Middle and South America |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Gold(i) and gold(iii) carbene complexes from the marine betaine norzooanemonin: inhibition of thioredoxin reductase, antiproliferative and antimicrobial activity. | Mahdavi SM, Bockfeld D, Esarev IV, Lippmann P, Frank R, Bronstrup M, Ott I, Tamm M. | RSC Med Chem | 10.1039/d4md00358f | 2024 | ||
| An organometallic hybrid antibiotic of metronidazole with a Gold(I) N-Heterocyclic Carbene overcomes metronidazole resistance in Clostridioides difficile. | Bussing R, Bublitz A, Karge B, Bronstrup M, Strowig T, Ott I. | J Biol Inorg Chem | 10.1007/s00775-024-02064-y | 2024 | ||
| Enzymology | Silver Organometallics that are Highly Potent Thioredoxin and Glutathione Reductase Inhibitors: Exploring the Correlations of Solution Chemistry with the Strong Antibacterial Effects. | Esarev IV, Karge B, Zeng H, Lippmann P, Jones PG, Schrey H, Bronstrup M, Ott I. | ACS Infect Dis | 10.1021/acsinfecdis.4c00104 | 2024 | |
| Pathogenicity | Gold(I) and Gold(III) N-Heterocyclic Carbene Complexes as Antibacterial Agents and Inhibitors of Bacterial Thioredoxin Reductase. | Bussing R, Karge B, Lippmann P, Jones PG, Bronstrup M, Ott I. | ChemMedChem | 10.1002/cmdc.202100381 | 2021 | |
| Biscarbene gold(i) complexes: structure-activity-relationships regarding antibacterial effects, cytotoxicity, TrxR inhibition and cellular bioavailability. | Schmidt C, Karge B, Misgeld R, Prokop A, Bronstrup M, Ott I. | Medchemcomm | 10.1039/c7md00269f | 2017 |
| #6393 | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 24068 |
| #20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 ) |
| #68369 | Automatically annotated from API 20NE . |
| #126262 | A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 ) |
You found an error in BacDive? Please tell us about it!
Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.
Successfully sent
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive12794.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data